TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

The National Pharmaceutical Pricing Authority (NPPA) approved an increase in the price of 11 formulations of eight drugs to ...

Upstream Bio's verekitug targets severe asthma, CRSwNP, and COPD, with promising early phase 2 data expected in 2025 and 2026 ...

Weight-loss drugs like Ozempic are transforming the fight against obesity, but they are forcing us to face crucial questions ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

steroid drugs have been the mainstay medication for asthma exacerbation; the trials have revealed that a single dose can be more effective when injected at the point of asthma exacerbation compared to ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from respiratory syncytial virus (RSV) in high-risk babies and young children - as ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Wheezing, shortness of breath, tightness in the chest: the symptoms of an asthma attack can be scary, especially for children. But, a new study suggests that pregnant women may have some agency over ...